The description of the protein encoded in this ORF: Firefly luciferase
The translational frameshift (ribosome slippage) involved: 0
The ribosome read-through involved: no
The alternative forms of this protein occur by the alternative initiation of translation: not tested
The ORF absolute position (the base range includes START and STOP codons or their equivalents): 2097-3749
Remarks:
The cloned 5'-UTR by van Eden et al. (2004) region was not a complete 5'-UTR. There are 3 mutations in
the cloned sequence provided by R. Lloyd in comparison to both German and NIH cDNA projects: GI:34367137 and
GI:22382083. -297nt from initiator ATG is A instead of G, -177nt is A instead of T, -76nt is G instead of T.
As already mentioned the sequence provided to IRESite by R. Lloyd spans -1115 to +4 (while the +4 base not
shown in van Eden et al. (2004) Fig. 1A is 'G'. van Eden showed already published 5'-UTR of NM_001166.2
(GI:10880127) GenBank record which is 1159b long whereas current GI:41349435 (NM_001166.3) contains 1.4kb
untranslated region.
The intercistronic region contains incomplete 5'-UTR of c-IAP1 (-1115 to -1) followed by some 19 b as a
remnant of HCV ORF after mutation.
Integrity of T7 in vitro transcript was verified by glyoxal/DMSO-agarose gel electrophoresis after previous
column purification and DNAse treatment followed by phenol:chloroform (1:1) extraction. Integrity of RNA 8 hrs
after direct RNA transfection was confirmed by RT-PCR in human HEK 293T/17 cells (Fig. 5D).
The relative translation efficiency in % of this IRES: 60.900
Name of IRES used as the positive control: HCV_type_1b
Name of the plasmid used as the positive control. pRL-HCV-FL-polyA
Name of the plasmid used as the negative control. pRL-FL-polyA
IRESite Id of the plasmid used as positive control. 112
IRESite Id of the plasmid used as negative control. 133
The relative translation efficiency in % of the positive control: 100.000
The relative translation efficiency in % of the negative control: 16.100
The size (length) of intercistronic region in the positive control: 419
The size (length) of intercistronic region in the negative control: 28
The effect of 5'-cap analogs on translation: not tested
Rapamycin affects translation: not tested
Type of RNA subject to translation: exogenous_RNA_with_GpppG_cap_with_polyA_tail
Remarks:
The more appropriate negative control pRL-null-FL-polyA said to contain 590nt spacer derived from human PKR.
We conclude part of the protein coding region was cloned, unfortunately it is not clear which exactly. For
example, GenBank GI:4506102 has 1654b long ORF. This negative control had activity of 25% of the positive
control.
The best negative control was pRL-revHCV-FL-polyA (IRESite ID:130) with 0% activity of the positive control.
See Fig. 5C.
The relative translation efficiency in % of this IRES: 88.100
Name of IRES used as the positive control: HCV_type_1b
Name of the plasmid used as the positive control. pRL-HCV-FL-polyA
Name of the plasmid used as the negative control. pRL-FL-polyA
IRESite Id of the plasmid used as positive control. 112
IRESite Id of the plasmid used as negative control. 133
The relative translation efficiency in % of the positive control: 100.000
The relative translation efficiency in % of the negative control: 22.500
The size (length) of intercistronic region in the positive control: 419
The size (length) of intercistronic region in the negative control: 28
The effect of 5'-cap analogs on translation: not tested
Rapamycin affects translation: not tested
Type of RNA subject to translation: exogenous_RNA_with_GpppG_cap_with_polyA_tail
Remarks:
The more appropriate negative control pRL-null-FL-polyA said to contain 590nt spacer derived from human PKR.
We conclude part of the protein coding region was cloned, unfortunately it is not clear which exactly. For
example, GenBank GI:4506102 has 1654b long ORF. This negative control had activity of 54.4% of the positive
control.
The best negative control was pRL-revHCV-FL-polyA (IRESite ID:130) with 0% activity of the positive control.
See Fig. 5C.
The relative translation efficiency in % of this IRES: 65.200
Name of IRES used as the positive control: HCV_type_1b
Name of the plasmid used as the positive control. pRL-HCV-FL-polyA
Name of the plasmid used as the negative control. pRL-FL-polyA
IRESite Id of the plasmid used as positive control. 112
IRESite Id of the plasmid used as negative control. 133
The relative translation efficiency in % of the positive control: 100.000
The relative translation efficiency in % of the negative control: 17.400
The size (length) of intercistronic region in the positive control: 419
The size (length) of intercistronic region in the negative control: 28
The effect of 5'-cap analogs on translation: not tested
Rapamycin affects translation: not tested
Type of RNA subject to translation: exogenous_RNA_with_GpppG_cap_with_polyA_tail
Remarks:
The more appropriate negative control pRL-null-FL-polyA is said to contain 590nt spacer derived from human
PKR. We conclude part of the protein coding region was cloned, unfortunately it is not clear which exactly.
For example, GenBank GI:4506102 has 1654b long ORF. This negative control had activity of 0% of the positive
control.
The best negative control was pRL-revHCV-FL-polyA (IRESite ID:130) with 0% activity of the positive control.
See Fig. 5C.